TAS::75 0850: TAS recovery act tissue samples and data from various types of cancer for the cancer genome atlas (TCGA) program
Ended Awarded Last action
- Contract number
- HHSN261201000005I
- Awardee
-
Cureline Inc. UEI JCKXB228KRH3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $212,611 obligated
Award facts
- Opportunity
-
- RECOVERY- Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $212,611 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 31% used
- $690,160.80
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This is a single-award Indefinite Delivery Contract (IDC) issued by the National Cancer Institute (NCI), a civilian federal agency, to Cureline Inc., a woman-owned small business. The contract has a total ceiling value of $690,160.80 and is for the procurement of various human tissue samples to support the NCI Cancer Genome Atlas (TCGA) Program.
The contract includes a firm fixed-price delivery order with a ceiling value of $212,610.63 for the purchase of breast ductal, colon, head and neck, lung adenocarcinoma, lung squamous, kidney renal, stomach, uterine corpus, and melanoma tissue samples. This delivery order is set aside for small businesses and has an ultimate completion date of January 24, 2015. The place of performance is Burlingame, CA. The contract is issued under the NCI Cancer Genome Atlas Program Tissue Purchase IDIQ vehicle, which provides a streamlined mechanism for the agency to acquire the necessary tissue samples to support its cancer research initiatives.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| TAS::75 0850:: TAS RFQ-NCI-100019-as HHSN261201000005I breast ductal, colon, head and neck, lung adeno, lung… | National Cancer Institute (NIH) | $212,611 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000005I?
HHSN261201000005I was awarded to Cureline Inc. by National Cancer Institute (National Institutes of Health) on January 25, 2010.
How much is contract HHSN261201000005I worth?
Orders under HHSN261201000005I have obligated $212,611. HHSN261201000005I's own ceiling is $690,161.
How many orders have been placed under contract HHSN261201000005I?
1 order has been placed under HHSN261201000005I, the latest on January 25, 2010.
Who can order from contract HHSN261201000005I?
HHSN261201000005I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000005I part of a contract vehicle?
Yes. HHSN261201000005I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000005I competed?
The extent of competition for HHSN261201000005I was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV